CRIS

$9.13
-$0.58 (-6.0%)
Closing price March 4, 2021
Curis shares are on the run again. This time it’s due to a secondary offering.
Curis has announced preliminary data from its ongoing early-stage study in patients with acute myeloid leukemia or high-risk myelodysplastic syndromes.